Search Results for 'generics'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Promotions & Moves
Endo Appoints EVP and CCO, Sterile and Generics
Ciarico to lead commercial strategy and execution for Endo's Generics Pharmaceutical and Sterile Injectable businesses08.01.19
-
Industry News
Sanofi Sells European Generics Biz
To focus on core areas of global medicines and emerging markets, specialty care and diabetes and cardiovascular06.29.18
-
Breaking News | Industry News
Sanofi in Talks to Sell Generics Biz for $2.4B
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business04.17.18
-
Breaking News | Industry News | Solid Dosage/Semi-solids
Sawai Pays $1bn for Generics Biz of Upsher-Smith
Acquisition marks a major expansion of Sawai's presence in the U.S. market04.26.17
-
Breaking News | Industry News
Experts Advocate Single Reference Product for Generics and 3D Printed Personalized Formulations
Big data forecast to revolutionize pharma’s operations, from outsourcing thorough to drug discovery10.05.16
-
Biosimilars | Clinical Trials
Indian Generics Expand in mAbs
As they focus on generic biologics, Indian firms are setting their sights on monoclonal antibodiesS. Harachand, Contributing Editor 07.21.14
-
Injectables
Generics: The Great Game-Changer
Equation-changing deals blaze up the CMO stageS. Harachand 01.22.10
-
Breaking News | Industry News
Mylan Acquires Merck KGaA's Generics Businesses
Mylan, Inc. has acquired Merck KGaA's Central and Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. Mylan exercised its option to acquire these businesses as part of a pr…06.02.08
-
APIs | Chemistry | Injectables | R&D
-
Breaking News | Industry News
Mylan Wins Merck Generics Auction
Mylan Laboratories, Inc. has signed a definitive agreement to acquire Merck KGaA's generics business (Merck Generics) for $6.7 billion in cash. The combination of the two companies will create an integrated global generics and specialty pharmaceutica…05.14.07
